This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

EU Pharmaceutical Law Forum
EU Pharmaceutical Law Forum 2024
May 21-23, 2024Steigenberger Wiltcher's, Brussels

Héctor Armengod
Partner at Latham & Watkins


Héctor Armengod is a partner in the Brussels office of Latham & Watkins and Vice Chair of the firm's Global Antitrust & Competition Practice. He advises clients on EU and Spanish competition law. In particular, Mr. Armengod represents clients in merger control proceedings before the European Commission and the Spanish Competition Authority. He also represents clients in major European Commission cartel and Art. 102 TFEU investigations. 

Mr. Armengod has extensive experience in the pharmaceutical and medical device sectors, having counseled clients on the compatibility with competition law of complex licensing, joint venture, distribution, co-promotion, co-marketing, and co-operation agreements. He also advises clients on compliance with EU and Spanish regulations in the field of medicinal products and medical devices, including promotion and marketing of products, interactions with healthcare professionals, and obligations related to authorization and placing on the market.

Prior to joining Latham, Mr. Armengod worked as competition lawyer at an international law firm in Brussels and in the Brussels and Madrid office of a Spanish law firm. He gained insight into the workings of the European Commission during an internship with the Competition Directorate General of the European Commission.

Mr. Armengod regularly writes on EU and Spanish competition law, and on EU life sciences regulatory topics.

Agenda Sessions

  • PANEL Merger Control and Expanded Jurisdictional Reach Developments and Strategy